# Applying a modified systematic review and integrated assessment framework (SYRINA) – a case study on triphenyl phosphate

## TL;DR

This paper uses a systematic review framework to assess if triphenyl phosphate is an endocrine disruptor based on its effects on metabolism and reproduction.

## Contribution

The study demonstrates the application and optimization of the SYRINA framework for evaluating endocrine disrupting potential of chemicals.

## Key findings

- Triphenyl phosphate was identified as an endocrine disruptor based on metabolic and reproductive effects.
- The SYRINA framework proved suitable but required significant effort for in vitro data analysis.
- Challenges include harmonizing methods and integrating evidence consistently.

## Abstract

This work presents a case study in applying a systematic review framework (SYRINA) to the identification of chemicals as endocrine disruptors. The suitability and performance of the framework is tested with regard to the widely accepted World Health Organization definition of an endocrine disruptor (ED). The endocrine disrupting potential of triphenyl phosphate (TPP), a well-studied flame retardant reported to exhibit various endocrine related effects was assessed. We followed the 7 steps of the SYRINA framework, articulating the research objective via Populations, Exposures, Comparators, Outcomes (PECO) statements, performed literature search and screening, conducted study evaluation, performed data extraction and summarized and integrated the evidence. Overall, 66 studies, consisting of in vivo, in vitro and epidemiological data, were included. We concluded that triphenyl phosphate could be identified as an ED based on metabolic disruption and reproductive function. We found that the tools used in this case study and the optimizations performed on the framework were suitable to assess properties of EDs. A number of challenges and areas for methodological development in systematic appraisal of evidence relating to endocrine disrupting potential were identified; significant time and effort were needed for the analysis of in vitro mechanistic data in this case study, thus increasing the workload and time needed to perform the systematic review process. Further research and development of this framework with regards to grey literature (non-peer-reviewed literature) search, harmonization of study evaluation methods, more consistent evidence integration approaches and a pre-defined method to assess links between adverse effect and endocrine activity are recommended. It would also be advantageous to conduct more case studies for a chemical with less data than TPP.

This work presents a case study in applying a systematic review framework (SYRINA) to the identification of chemicals as endocrine disruptors.